PRRT2 and cancer: One of the most specific PKC inhibitors developed is chelerythrine24, a natural benzophenanthridine alkaloid isolated from Chelidonium majus and possesses diverse pharmacological activities including potent anti-cancer and cytotoxic activities25, 26.